Oxygen Biotherapeutics (OXBT) Reports In-Line Q1 Loss of $0.12
Tweet Send to a Friend
Oxygen Biotherapeutics (NASDAQ: OXBT) reported Q1 EPS of ($0.12) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
